ArticleFrontiers in genetics2018
Evolutionary Pattern and Large-Scale Architecture of Mutation Networks of 2009 A (H1N1) Influenza A Virus.
Article in Frontiers in genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology of influenza from 2017 to 2022 in a national children's regional medical center.BMC pediatrics · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adaptive evolution of influenza virus is an important question, but predicting its evolutionary future will be more challenging. Here, we investigated the mutation characteristic of influenza virus based on the complete genome data of 2009 (H1N1) influenza A virus. By assuming that evolution proceeds via the accumulation of mutations, we analyzed the mutation networks at four different time stages and found that the network structure follows the characteristics of a scale-free network. These results will be important for epidemiology and the future control of influenza viruses. Furthermore, we predicted the predominant mutation virus strain by using the early mutation network of influenza viruses, and this result was consistent with the WHO recommendation for the candidate vaccine of influenza virus. The key contribution of this study is that we explained the biological significance of this scale-free network for influenza pandemic and provided a potential method for predicting the candidate vaccine by using the early-stage network.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.